Safety of oleochemical products derived from beef tallow or bone fat regarding prions

European Journal of Lipid Science and Technology

Volumn 103, Issue 11, 2001, Pages 713-721

  Appel, Thomas Raul ^a   Riesner, Detlev ^b   Von Rheinbaben, Friedrich ^c   Heinzel, Michael ^c  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c HENKEL KGAA   (Germany)

Author keywords

Inactivation; Lipid; Prion; Tallow; TSE

Indexed keywords

EID: 0035540967     PISSN: 14387697     EISSN: None     Source Type: Journal    
DOI: 10.1002/1438-9312(200111)103:11<713::aid-ejlt713>3.0.co;2-c     Document Type: Article

References (30)

1. S. B. Prusiner: Novel proteinaceous infectious particles cause scrapie. Science 216 (1982) 136-144.
2. S. B. Prusiner: Prions. Proc. Natl. Acad. Sci. USA 95 (1998) 13363-13383.
3. A. Casolari: Heat resistance of prions and food processing. Food Microbiol. 15 (1998) 59-63.
4. K. Danner: Übertragung spongiformer Encephalopathien durch Arzneimittel, Grundzüge einer Risikobetrachtung. Pharm. Ind. 53 (1991) 614-619.
5. T. R. Klein, D. Kirsch, R. Kaufmann, D. Riesner: Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol. Chem. 379 (1998) 655-666.
6. T. R. Appel, C. Dumpitak, U. Matthiesen, D. Riesner: Prion rods contain an inert polysaccharide scaffold. Biol. Chem. 380 (1999) 1295-1306.
7. M. P. McKinley, D. C. Bolton, S. B. Prusiner: A protease-resistant protein is a structural component of the scrapie prion. Cell 35 (1983) 57-62.
8. R. Gabizon, M. P. McKinley, D. Groth, D. Westaway, S. J. DeArmond, G. A. Carlson, S. B. Prusiner: Immunoaffinity purification and neutralization of scrapie prions. Prog. Clin. Biol. Res. 317 (1989) 583-600.
9. P. Brown, P. P. Liberski, A. Wolff, C. G. Gajdusek: Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 °C: practical and theoretical implications. J. Inf. Dis. 161 (1990) 467-472.
10. M. Beekes, E. Baldauf, H. Diringer: Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J. Gen. Virol. 77 (1996) 1925-1934.
11. D. B. Volkin, A. M. Klibanov: Alterations in the structure of proteins that cause their irreversible inactivation. Dev. Biol. Stand. 74 (1991) 73-81.
12. F. E. Cohen: Protein misfolding and prion diseases. J. Mol. Biol. 293 (1999) 313-320.
13. N. Nathanson, J. Wilesmith, C. Griot: Bovine spongiform encephalopathy (BSE): causes and consequences of a common source epidemic. Am. J. Epidemiol. 145 (1997) 959-969.
14. st, 2001. http://www. defra.gov.uk/animalh/bse/index.html.
15. R. M. Anderson, C. A. Donnelly, N. M. Ferguson, M. E. Woolhouse, C. J. Watt, H. J. Udy, S. MaWhinney, S. P. Dunstan, T. R. Southwood, J. W. Wilesmith, J. B. Ryan, L. J. Hoinville, J. E. Hillerton, A. R. Austin, G. A. Wells: Transmission dynamics and epidemiology of BSE in British cattle. Nature 382 (1996) 779-788.
16. P. Brown: Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. BMJ 322 (2001) 841-844.
17. J. Collinge: Variant Creutzfeldt-Jakob disease. Lancet 354 (1999) 317-323.
18. th edition, Wiley-VCH, Weinheim (Germany), New York, Chichester, Brisbane, Singapore, Toronto 1999.
19. th, 1998.
20. European Commission directive 98/16/EC: Twenty-second commission directive of 5 March 1998 adapting to technical progress Annexes II, III, VI and VII to Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European Communities L77 (1998) 44-46.
21. T. R. Appel, M. Wolff, F. von Rheinbaben, M. Heinzel, D. Riesner: Heat Stability of Prion Rods and Prion Protein in Lipid, Water and Lipid/Water Mixtures. J. Gen. Virol. 82 (2001) 465-473.
22. H. Diringer, M. Beekes, M. Özel, D. Simon, I. Queck, F. Cardone, M. Pocchiari, J. W. Ironside: Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 40 (1997) 238-246.
23. I. Mehlhorn, D. Groth, J. Stöckel, B. Moffat, D. Teilly, D. Yansuro, W. S. Willet, M. Baldwin, E. Fletterick, F. E. Cohen, R. Vandlen, D. Henner, S. B. Prusiner: High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 35 (1996) 5528-5537.
24. D. Wessel, U. I. Flügge: A method for the quantitative recovery of protein in dilute solution in the presence of detergent and lipids. Anal. Biochem. 138 (1984) 141-143.
25. S. A. Priola, B. Caughey, K. Wehrly, B. Chesebro: A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. J. Biol. Chem. 270 (1995) 3299-3305.
26. R. C. Overthür: Inaktivierung von Prionen durch Hitze. In: Prionen und Prionkrankheiten. Eds. B. v. Hörnlimann, H. Kretschmar, D. Riesner, de Gruyter, Berlin (Germany) 2001, pp. 389-398.
27. EEC committee for proprietary medicinal products: Guidelines for Minimizing the Risk of Transmitting Agents Causing Spongiform Encephalopathy via Medicinal Products. Biologicals 20 (1992) 155-158.
28. F. Horaud: The safety of biologicals - old problems, new questions. In: Transmissible Spongiform Encephalopathies - Impact on Animal and Human Health. Ed. F. Brown, Dev. Biol. Stand. 80 (1993) 3-5.
29. th, 1995.
30. rd, 2001. http://www.doh.gov.uk/cjd/cjdstat.htm.